Product Overview
[Drug Name]
Generic Name: Ambroxol Hydrochloride Sustained-Release Capsules
Trade Name: Sanjiu Pharmaceutical Ambroxol Hydrochloride Sustained-Release Capsules 75mg*6 Capsules
Pinyin Code: SanJiuYiYao YanSuanAnZuoSuoHuanShiJiaoNang 75mg*6Li
[Main Ingredients]
Each capsule contains 75mg of ambroxol hydrochloride. Excipients include sucrose, starch, polyacrylic acid resin L100, diethyl phthalate, and talc.
[Properties]
This product is a hard capsule containing white or off-white spherical pellets.
[Indications/Main Functions]
It is suitable for patients with thick and difficult-to-cough sputum.
[Precautions]
1. Use with caution during pregnancy and lactation.
2. Consult a physician or pharmacist regarding dosage for children.
3. Avoid concomitant use with centrally acting antitussives (such as dextromethorphan) to prevent fine sputum from blocking the airways.
4. This product is a mucus regulator and is only effective for expectoration. When using this product, pay attention to the cause of the cough and expectoration. If no improvement occurs after 7 days of use, seek medical attention immediately.
5. In case of overdose or serious adverse reactions, seek medical attention immediately.
6. Contraindicated for those allergic to this product. Use with caution for those with allergies.
7. Do not use if this product changes shape.
8. Children must be supervised before use.
9. Keep out of reach of children.
10. If you are taking other medications, consult a physician or pharmacist before using this product.
[Drug Interactions]
Not yet known.
[Pediatric Use]
Not yet known.
[Elderly Use]
Not yet known.
[Use during Pregnancy and Lactation]
Unknown.
[Specification]
75mg*6 capsules
[Dosage and Administration]
Oral. Adults, 1 tablet once daily.
[Adverse Reactions]
Occasionally, rash, nausea, stomach discomfort, loss of appetite, abdominal pain, and diarrhea may occur.
[Contraindications]
Unknown.
[Overdose]
Unknown.
[Pharmacology and Toxicology]
This product is a macrosoluble agent that increases the secretion of respiratory mucosal fluid and reduces mucus gland secretion, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, and increasing bronchial ciliary motility, making sputum easier to expectorate.
[Pharmacokinetics]
Unknown.
